Change in Fetal Urine Production Rate in Growth‐Restricted Fetuses After Maternal Meal Ingestion

I. Yasuhi,M. Hirai,T. Ishimaru,T. Yamabe

DOI: https://doi.org/10.1016/0029-7844(96)00274-8

1996-11-01

Obstetrics and Gynecology

Abstract:

What problem does this paper attempt to address?

AI in Pathology: What could possibly go wrong?

Keisuke Nakagawa,Lama Moukheiber,Malhar Patel,Faisal Mahmood,Dibson Gondim,Michael Hogarth,Richard Levenson,Leo Celi

DOI: https://doi.org/10.1053/j.semdp.2023.02.006

IF: 3.893

2023-03-03

Seminars in Diagnostic Pathology

Abstract:The field of medicine is undergoing rapid digital transformation. Pathologists are now striving to digitize their data, workflows, and interpretations, assisted by the enabling development of whole-slide imaging. Going digital means that the analog process of human diagnosis can be augmented or even replaced by rapidly evolving AI approaches, which are just now entering into clinical practice. But with such progress comes challenges that reflect a variety of stressors, including the impact of unrepresentative training data with accompanying implicit bias, data privacy concerns, and fragility of algorithm performance. Beyond such core digital aspects, considerations arise related to difficulties presented by changing disease presentations, diagnostic approaches, and therapeutic options. While some tools such as data federation can help with broadening data diversity while preserving expertise and local control, they may not be the full answer to some of these issues. The impact of AI in pathology on the field's human practitioners is still very much unknown: installation of unconscious bias and deference to AI guidance need to be understood and addressed. If AI is widely adopted, it may remove many inefficiencies in daily practice and compensate for staff shortages. It may also cause practitioner deskilling, dethrilling, and burnout. We discuss the technological, clinical, legal, and sociological factors that will influence the adoption of AI in pathology, and its eventual impact for good or ill.

pathology,medical laboratory technology
Shelf-stable and safe intermediate-moisture meat products using hurdle technology.

Sweetie R. Kanatt,S. P. Chawla,R. Chander,D. Bongirwar

DOI: https://doi.org/10.4315/0362-028X-65.10.1628

IF: 2.745

2002-10-01

Journal of Food Protection

Abstract:A number of ready-to-use shelf-stable intermediate-moisture (IM) spiced mutton and spiced chicken products were developed with a combination of hurdles (reduced moisture, vacuum packing, and irradiation). The water activity of the products was reduced to about 0.80 either by grilling or by hot-air drying. These IM products were vacuum packed and subjected to gamma radiation processing at 0 to 10 kGy. Microbiological analyses revealed a radiation dose-dependent reduction in total viable counts and in numbers of Staphylococcus species. IM meat products that did not undergo radiation treatment showed visible mold growth within 2 months. The products subjected to irradiation at 10 kGy showed an absence of viable microorganisms and also retained high sensory acceptability for up to 9 months at ambient temperatures.
General Roadmap and Core Steps for the Development of AI Tools in Digital Pathology

Yasmine Makhlouf,Manuel Salto-Tellez,Jacqueline James,Paul O’Reilly,Perry Maxwell

DOI: https://doi.org/10.3390/diagnostics12051272

IF: 3.6

2022-05-20

Diagnostics

Abstract:Integrating Artificial Intelligence (AI) tools in the tissue diagnostic workflow will benefit the pathologist and, ultimately, the patient. The generation of such AI tools has two parallel yet interconnected processes, namely the definition of the pathologist's task to be delivered in silico, and the software development requirements. In this review paper, we demystify this process, from a viewpoint that joins experienced pathologists and data scientists, by proposing a general pathway and describing the core steps to build an AI digital pathology tool. In doing so, we highlight the importance of the collaboration between AI scientists and pathologists, from the initial formulation of the hypothesis to the final, ready-to-use product.

medicine, general & internal
Artificial intelligence in diagnostic pathology

Saba Shafi,Anil V Parwani,Anil V. Parwani

DOI: https://doi.org/10.1186/s13000-023-01375-z

2023-10-04

Diagnostic Pathology

Abstract:Digital pathology (DP) is being increasingly employed in cancer diagnostics, providing additional tools for faster, higher-quality, accurate diagnosis. The practice of diagnostic pathology has gone through a staggering transformation wherein new tools such as digital imaging, advanced artificial intelligence (AI) algorithms, and computer-aided diagnostic techniques are being used for assisting, augmenting and empowering the computational histopathology and AI-enabled diagnostics. This is paving the way for advancement in precision medicine in cancer. Automated whole slide imaging (WSI) scanners are now rendering diagnostic quality, high-resolution images of entire glass slides and combining these images with innovative digital pathology tools is making it possible to integrate imaging into all aspects of pathology reporting including anatomical, clinical, and molecular pathology. The recent approvals of WSI scanners for primary diagnosis by the FDA as well as the approval of prostate AI algorithm has paved the way for starting to incorporate this exciting technology for use in primary diagnosis. AI tools can provide a unique platform for innovations and advances in anatomical and clinical pathology workflows. In this review, we describe the milestones and landmark trials in the use of AI in clinical pathology with emphasis on future directions.

pathology
Artificial Intelligence for Digital and Computational Pathology

Andrew H. Song,Guillaume Jaume,Drew F.K. Williamson,Ming Y. Lu,Anurag Vaidya,Tiffany R. Miller,Faisal Mahmood

DOI: https://doi.org/10.48550/arXiv.2401.06148

2023-12-13

Image and Video Processing

Abstract:Advances in digitizing tissue slides and the fast-paced progress in artificial intelligence, including deep learning, have boosted the field of computational pathology. This field holds tremendous potential to automate clinical diagnosis, predict patient prognosis and response to therapy, and discover new morphological biomarkers from tissue images. Some of these artificial intelligence-based systems are now getting approved to assist clinical diagnosis; however, technical barriers remain for their widespread clinical adoption and integration as a research tool. This Review consolidates recent methodological advances in computational pathology for predicting clinical end points in whole-slide images and highlights how these developments enable the automation of clinical practice and the discovery of new biomarkers. We then provide future perspectives as the field expands into a broader range of clinical and research tasks with increasingly diverse modalities of clinical data.
AI in Computational Pathology of Cancer: Improving Diagnostic Workflows and Clinical Outcomes?

Didem Cifci,Gregory P. Veldhuizen,Sebastian Foersch,Jakob Nikolas Kather

DOI: https://doi.org/10.1146/annurev-cancerbio-061521-092038

2023-04-12

Annual Review of Cancer Biology

Abstract:Histopathology plays a fundamental role in the diagnosis and subtyping of solid tumors and has become a cornerstone of modern precision oncology. Histopathological evaluation is typically performed manually by expert pathologists due to the complexity of visual data. However, in the last ten years, new artificial intelligence (AI) methods have made it possible to train computers to perform visual tasks with high performance, reaching similar levels as experts in some applications. In cancer histopathology, these AI tools could help automate repetitive tasks, making more efficient use of pathologists’ time. In research studies, AI methods have been shown to have an astounding ability to predict genetic alterations and identify prognostic and predictive biomarkers directly from routine tissue slides. Here, we give an overview of these recent applications of AI in computational pathology, focusing on new tools for cancer research that could be pivotal in identifying clinical biomarkers for better treatment decisions.

oncology
Multi-modality artificial intelligence in digital pathology

Yixuan Qiao,Lianhe Zhao,Chunlong Luo,Yufan Luo,Yang Wu,Shengtong Li,Dechao Bu,Yi Zhao

DOI: https://doi.org/10.1093/bib/bbac367

IF: 9.5

2022-09-16

Briefings in Bioinformatics

Abstract:Abstract In common medical procedures, the time-consuming and expensive nature of obtaining test results plagues doctors and patients. Digital pathology research allows using computational technologies to manage data, presenting an opportunity to improve the efficiency of diagnosis and treatment. Artificial intelligence (AI) has a great advantage in the data analytics phase. Extensive research has shown that AI algorithms can produce more up-to-date and standardized conclusions for whole slide images. In conjunction with the development of high-throughput sequencing technologies, algorithms can integrate and analyze data from multiple modalities to explore the correspondence between morphological features and gene expression. This review investigates using the most popular image data, hematoxylin–eosin stained tissue slide images, to find a strategic solution for the imbalance of healthcare resources. The article focuses on the role that the development of deep learning technology has in assisting doctors’ work and discusses the opportunities and challenges of AI.

biochemical research methods,mathematical & computational biology
A pathologist–AI collaboration framework for enhancing diagnostic accuracies and efficiencies

Zhi Huang,Eric Yang,Jeanne Shen,Dita Gratzinger,Frederick Eyerer,Brooke Liang,Jeffrey Nirschl,David Bingham,Alex M. Dussaq,Christian Kunder,Rebecca Rojansky,Aubre Gilbert,Alexandra L. Chang-Graham,Brooke E. Howitt,Ying Liu,Emily E. Ryan,Troy B. Tenney,Xiaoming Zhang,Ann Folkins,Edward J. Fox,Kathleen S. Montine,Thomas J. Montine,James Zou

DOI: https://doi.org/10.1038/s41551-024-01223-5

IF: 28.1

2024-06-19

Nature Biomedical Engineering

Abstract:In pathology, the deployment of artificial intelligence (AI) in clinical settings is constrained by limitations in data collection and in model transparency and interpretability. Here we describe a digital pathology framework, nuclei.io, that incorporates active learning and human-in-the-loop real-time feedback for the rapid creation of diverse datasets and models. We validate the effectiveness of the framework via two crossover user studies that leveraged collaboration between the AI and the pathologist, including the identification of plasma cells in endometrial biopsies and the detection of colorectal cancer metastasis in lymph nodes. In both studies, nuclei.io yielded considerable diagnostic performance improvements. Collaboration between clinicians and AI will aid digital pathology by enhancing accuracies and efficiencies.

engineering, biomedical
Implementation of Digital Pathology and Artificial Intelligence in Routine Pathology Practice

David Y Zhang,Arsha Venkat,Hamdi Khasawneh,Rasoul Sali,Valerio Zhang,Zhiheng Pei

DOI: https://doi.org/10.1016/j.labinv.2024.102111

2024-07-23

Abstract:The advent of affordable technology has significantly influenced the practice of digital pathology, leading to its growing adoption within the pathology community. This review article aimed to outline the latest developments in digital pathology, the cutting-edge advancements in artificial intelligence (AI) applications within this field, and the pertinent United States regulatory frameworks. The content is based on a thorough analysis of original research articles and official United States Federal guidelines. Findings from our review indicate that several Food and Drug Administration-approved digital scanners and image management systems are establishing a solid foundation for the seamless integration of advanced technologies into everyday pathology workflows, which may reduce device and operational costs in the future. AI is particularly transforming the way morphologic diagnoses are automated, notably in cancers like prostate and colorectal, within screening initiatives, albeit challenges such as data privacy issues and algorithmic biases remain. The regulatory environment, shaped by standards from the Food and Drug Administration, Centers for Medicare & Medicaid Services/Clinical Laboratory Improvement Amendments, and College of American Pathologists, is evolving to accommodate these innovations while ensuring safety and reliability. Centers for Medicare & Medicaid Services/Clinical Laboratory Improvement Amendments have issued policies to allow pathologists to review and render diagnoses using digital pathology remotely. Moreover, the introduction of new digital pathology Current Procedural Terminology codes designed to complement existing pathology Current Procedural Terminology codes is facilitating reimbursement processes. Overall, these advancements are heralding a new era in pathology that promises enhanced diagnostic precision and efficiency through digital and AI technologies, potentially improving patient care as well as bolstering educational and research activities.
Artificial intelligence in histopathology: enhancing cancer research and clinical oncology

Artem Shmatko,Narmin Ghaffari Laleh,Moritz Gerstung,Jakob Nikolas Kather

DOI: https://doi.org/10.1038/s43018-022-00436-4

IF: 22.7

2022-09-23

Nature Cancer

Abstract:Artificial intelligence (AI) methods have multiplied our capabilities to extract quantitative information from digital histopathology images. AI is expected to reduce workload for human experts, improve the objectivity and consistency of pathology reports, and have a clinical impact by extracting hidden information from routinely available data. Here, we describe how AI can be used to predict cancer outcome, treatment response, genetic alterations and gene expression from digitized histopathology slides. We summarize the underlying technologies and emerging approaches, noting limitations, including the need for data sharing and standards. Finally, we discuss the broader implications of AI in cancer research and oncology.
Towards the Augmented Pathologist: Challenges of Explainable-AI in Digital Pathology

Andreas Holzinger,Bernd Malle,Peter Kieseberg,Peter M. Roth,Heimo Müller,Robert Reihs,Kurt Zatloukal

DOI: https://doi.org/10.48550/arXiv.1712.06657

IF: 14.4

2017-12-18

Artificial Intelligence

Abstract:Digital pathology is not only one of the most promising fields of diagnostic medicine, but at the same time a hot topic for fundamental research. Digital pathology is not just the transfer of histopathological slides into digital representations. The combination of different data sources (images, patient records, and *omics data) together with current advances in artificial intelligence/machine learning enable to make novel information accessible and quantifiable to a human expert, which is not yet available and not exploited in current medical settings. The grand goal is to reach a level of usable intelligence to understand the data in the context of an application task, thereby making machine decisions transparent, interpretable and explainable. The foundation of such an "augmented pathologist" needs an integrated approach: While machine learning algorithms require many thousands of training examples, a human expert is often confronted with only a few data points. Interestingly, humans can learn from such few examples and are able to instantly interpret complex patterns. Consequently, the grand goal is to combine the possibilities of artificial intelligence with human intelligence and to find a well-suited balance between them to enable what neither of them could do on their own. This can raise the quality of education, diagnosis, prognosis and prediction of cancer and other diseases. In this paper we describe some (incomplete) research issues which we believe should be addressed in an integrated and concerted effort for paving the way towards the augmented pathologist.
Advancements in computer vision and pathology: Unraveling the potential of artificial intelligence for precision diagnosis and beyond

Justin Chang,Bryce Hatfield

DOI: https://doi.org/10.1016/bs.acr.2024.05.006

Abstract:The integration of computer vision into pathology through slide digitalization represents a transformative leap in the field's evolution. Traditional pathology methods, while reliable, are often time-consuming and susceptible to intra- and interobserver variability. In contrast, computer vision, empowered by artificial intelligence (AI) and machine learning (ML), promises revolutionary changes, offering consistent, reproducible, and objective results with ever-increasing speed and scalability. The applications of advanced algorithms and deep learning architectures like CNNs and U-Nets augment pathologists' diagnostic capabilities, opening new frontiers in automated image analysis. As these technologies mature and integrate into digital pathology workflows, they are poised to provide deeper insights into disease processes, quantify and standardize biomarkers, enhance patient outcomes, and automate routine tasks, reducing pathologists' workload. However, this transformative force calls for cross-disciplinary collaboration between pathologists, computer scientists, and industry innovators to drive research and development. While acknowledging its potential, this chapter addresses the limitations of AI in pathology, encompassing technical, practical, and ethical considerations during development and implementation.
Emerging role of deep learning-based artificial intelligence in tumor pathology

Yahui Jiang,Meng Yang,Shuhao Wang,Xiangchun Li,Yan Sun

DOI: https://doi.org/10.1002/cac2.12012

IF: 15.2825

2020-01-01

Cancer Communications

Abstract:The development of digital pathology and progression of state-of-the-art algorithms for computer vision have led to increasing interest in the use of artificial intelligence (AI), especially deep learning (DL)-based AI, in tumor pathology. The DL-based algorithms have been developed to conduct all kinds of work involved in tumor pathology, including tumor diagnosis, subtyping, grading, staging, and prognostic prediction, as well as the identification of pathological features, biomarkers and genetic changes. The applications of AI in pathology not only contribute to improve diagnostic accuracy and objectivity but also reduce the workload of pathologists and subsequently enable them to spend additional time on high-level decision-making tasks. In addition, AI is useful for pathologists to meet the requirements of precision oncology. However, there are still some challenges relating to the implementation of AI, including the issues of algorithm validation and interpretability, computing systems, the unbelieving attitude of pathologists, clinicians and patients, as well as regulators and reimbursements. Herein, we present an overview on how AI-based approaches could be integrated into the workflow of pathologists and discuss the challenges and perspectives of the implementation of AI in tumor pathology.
Digital pathology and artificial intelligence in translational medicine and clinical practice

Vipul Baxi,Robin Edwards,Michael Montalto,Saurabh Saha

DOI: https://doi.org/10.1038/s41379-021-00919-2

IF: 8.209

2021-10-05

Modern Pathology

Abstract:Abstract Traditional pathology approaches have played an integral role in the delivery of diagnosis, semi-quantitative or qualitative assessment of protein expression, and classification of disease. Technological advances and the increased focus on precision medicine have recently paved the way for the development of digital pathology-based approaches for quantitative pathologic assessments, namely whole slide imaging and artificial intelligence (AI)–based solutions, allowing us to explore and extract information beyond human visual perception. Within the field of immuno-oncology, the application of such methodologies in drug development and translational research have created invaluable opportunities for deciphering complex pathophysiology and the discovery of novel biomarkers and drug targets. With an increasing number of treatment options available for any given disease, practitioners face the growing challenge of selecting the most appropriate treatment for each patient. The ever-increasing utilization of AI-based approaches substantially expands our understanding of the tumor microenvironment, with digital approaches to patient stratification and selection for diagnostic assays supporting the identification of the optimal treatment regimen based on patient profiles. This review provides an overview of the opportunities and limitations around implementing AI-based methods in biomarker discovery and patient selection and discusses how advances in digital pathology and AI should be considered in the current landscape of translational medicine, touching on challenges this technology may face if adopted in clinical settings. The traditional role of pathologists in delivering accurate diagnoses or assessing biomarkers for companion diagnostics may be enhanced in precision, reproducibility, and scale by AI-powered analysis tools.

pathology
Preparing Data for Artificial Intelligence in Pathology with Clinical-Grade Performance

Yuanqing Yang,Kai Sun,Yanhua Gao,Kuansong Wang,Gang Yu

DOI: https://doi.org/10.3390/diagnostics13193115

IF: 3.6

2023-10-04

Diagnostics

Abstract:The pathology is decisive for disease diagnosis but relies heavily on experienced pathologists. In recent years, there has been growing interest in the use of artificial intelligence in pathology (AIP) to enhance diagnostic accuracy and efficiency. However, the impressive performance of deep learning-based AIP in laboratory settings often proves challenging to replicate in clinical practice. As the data preparation is important for AIP, the paper has reviewed AIP-related studies in the PubMed database published from January 2017 to February 2022, and 118 studies were included. An in-depth analysis of data preparation methods is conducted, encompassing the acquisition of pathological tissue slides, data cleaning, screening, and subsequent digitization. Expert review, image annotation, dataset division for model training and validation are also discussed. Furthermore, we delve into the reasons behind the challenges in reproducing the high performance of AIP in clinical settings and present effective strategies to enhance AIP's clinical performance. The robustness of AIP depends on a randomized collection of representative disease slides, incorporating rigorous quality control and screening, correction of digital discrepancies, reasonable annotation, and sufficient data volume. Digital pathology is fundamental in clinical-grade AIP, and the techniques of data standardization and weakly supervised learning methods based on whole slide image (WSI) are effective ways to overcome obstacles of performance reproduction. The key to performance reproducibility lies in having representative data, an adequate amount of labeling, and ensuring consistency across multiple centers. Digital pathology for clinical diagnosis, data standardization and the technique of WSI-based weakly supervised learning will hopefully build clinical-grade AIP.

medicine, general & internal
Emerging Role of Deep Learning‐based Artificial Intelligence in Tumor Pathology

Yahui Jiang,Meng Yang,Shuhao Wang,Xiangchun Li,Yan Sun

DOI: https://doi.org/10.1002/cac2.12012

IF: 15.2825

2020-01-01

Cancer Communications

Abstract:The development of digital pathology and progression of state‐of‐the‐art algorithms for computer vision have led to increasing interest in the use of artificial intelligence (AI), especially deep learning (DL)‐based AI, in tumor pathology. The DL‐based algorithms have been developed to conduct all kinds of work involved in tumor pathology, including tumor diagnosis, subtyping, grading, staging, and prognostic prediction, as well as the identification of pathological features, biomarkers and genetic changes. The applications of AI in pathology not only contribute to improve diagnostic accuracy and objectivity but also reduce the workload of pathologists and subsequently enable them to spend additional time on high‐level decision‐making tasks. In addition, AI is useful for pathologists to meet the requirements of precision oncology. However, there are still some challenges relating to the implementation of AI, including the issues of algorithm validation and interpretability, computing systems, the unbelieving attitude of pathologists, clinicians and patients, as well as regulators and reimbursements. Herein, we present an overview on how AI‐based approaches could be integrated into the workflow of pathologists and discuss the challenges and perspectives of the implementation of AI in tumor pathology.
Improving Workflow Integration with xPath: Design and Evaluation of a Human-AI Diagnosis System in Pathology

Hongyan Gu,Yuan Liang,Yifan Xu,Christopher Kazu Williams,Shino Magaki,Negar Khanlou,Harry Vinters,Zesheng Chen,Shuo Ni,Chunxu Yang,Wenzhong Yan,Xinhai Robert Zhang,Yang Li,Mohammad Haeri,Xiang ‘Anthony’ Chen

DOI: https://doi.org/10.1145/3577011

IF: 4.106

2023-03-18

ACM Transactions on Computer-Human Interaction

Abstract:Recent developments in AI have provided assisting tools to support pathologists’ diagnoses. However, it remains challenging to incorporate such tools into pathologists’ practice; one main concern is AI’s insufficient workflow integration with medical decisions. We observed pathologists’ examination and discovered that the main hindering factor to integrate AI is its incompatibility with pathologists’ workflow. To bridge the gap between pathologists and AI, we developed a human-AI collaborative diagnosis tool — xPath — that shares a similar examination process to that of pathologists, which can improve AI’s integration into their routine examination. The viability of xPath is confirmed by a technical evaluation and work sessions with twelve medical professionals in pathology. This work identifies and addresses the challenge of incorporating AI models into pathology, which can offer first-hand knowledge about how HCI researchers can work with medical professionals side-by-side to bring technological advances to medical tasks towards practical applications.

computer science, information systems, cybernetics
Pros and cons of artificial intelligence implementation in diagnostic pathology

Paul J van Diest,Rachel N Flach,Carmen van Dooijeweert,Seher Makineli,Gerben E Breimer,Nikolas Stathonikos,Paul Pham,Tri Q Nguyen,Mitko Veta

DOI: https://doi.org/10.1111/his.15153

2024-03-04

Histopathology

Abstract:Companies are introducing algorithms to the market, and questions arise whether the pathology community is ready for artificial intelligence (AI) integration in routine practices. However, concerns regarding AI use in pathology are emerging. This review discusses the pros and cons of introducing AI in diagnostic pathology. The rapid introduction of digital pathology has greatly facilitated development of artificial intelligence (AI) models in pathology that have shown great promise in assisting morphological diagnostics and quantitation of therapeutic targets. We are now at a tipping point where companies have started to bring algorithms to the market, and questions arise whether the pathology community is ready to implement AI in routine workflow. However, concerns also arise about the use of AI in pathology. This article reviews the pros and cons of introducing AI in diagnostic pathology.

pathology,cell biology
Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling

Albrecht Stenzinger,Maximilian Alber,Michael Allgäuer,Philipp Jurmeister,Michael Bockmayr,Jan Budczies,Jochen Lennerz,Johannes Eschrich,Daniel Kazdal,Peter Schirmacher,Alex H Wagner,Frank Tacke,David Capper,Klaus-Robert Müller,Frederick Klauschen

DOI: https://doi.org/10.1016/j.semcancer.2021.02.011

Abstract:The complexity of diagnostic (surgical) pathology has increased substantially over the last decades with respect to histomorphological and molecular profiling. Pathology has steadily expanded its role in tumor diagnostics and beyond from disease entity identification via prognosis estimation to precision therapy prediction. It is therefore not surprising that pathology is among the disciplines in medicine with high expectations in the application of artificial intelligence (AI) or machine learning approaches given their capabilities to analyze complex data in a quantitative and standardized manner to further enhance scope and precision of diagnostics. While an obvious application is the analysis of histological images, recent applications for the analysis of molecular profiling data from different sources and clinical data support the notion that AI will enhance both histopathology and molecular pathology in the future. At the same time, current literature should not be misunderstood in a way that pathologists will likely be replaced by AI applications in the foreseeable future. Although AI will transform pathology in the coming years, recent studies reporting AI algorithms to diagnose cancer or predict certain molecular properties deal with relatively simple diagnostic problems that fall short of the diagnostic complexity pathologists face in clinical routine. Here, we review the pertinent literature of AI methods and their applications to pathology, and put the current achievements and what can be expected in the future in the context of the requirements for research and routine diagnostics.

Change in Fetal Urine Production Rate in Growth‐Restricted Fetuses After Maternal Meal Ingestion

AI in Pathology: What could possibly go wrong?

Shelf-stable and safe intermediate-moisture meat products using hurdle technology.

General Roadmap and Core Steps for the Development of AI Tools in Digital Pathology

Artificial intelligence in diagnostic pathology

Artificial Intelligence for Digital and Computational Pathology

AI in Computational Pathology of Cancer: Improving Diagnostic Workflows and Clinical Outcomes?

Multi-modality artificial intelligence in digital pathology

A pathologist–AI collaboration framework for enhancing diagnostic accuracies and efficiencies

Implementation of Digital Pathology and Artificial Intelligence in Routine Pathology Practice

Artificial intelligence in histopathology: enhancing cancer research and clinical oncology

Towards the Augmented Pathologist: Challenges of Explainable-AI in Digital Pathology

Advancements in computer vision and pathology: Unraveling the potential of artificial intelligence for precision diagnosis and beyond

Emerging role of deep learning-based artificial intelligence in tumor pathology

Digital pathology and artificial intelligence in translational medicine and clinical practice

Preparing Data for Artificial Intelligence in Pathology with Clinical-Grade Performance

Emerging Role of Deep Learning‐based Artificial Intelligence in Tumor Pathology

Improving Workflow Integration with xPath: Design and Evaluation of a Human-AI Diagnosis System in Pathology

Pros and cons of artificial intelligence implementation in diagnostic pathology

Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling